Rituximab Prevents the Development of Experimental Autoimmune Encephalomyelitis (EAE): Comparison with Prophylactic, Therapeutic or Combinational Regimens
Mena R Al-ani,1 Tom K Raju,2 Mahmood Y Hachim,1,2 Ibrahim Y Hachim,1 Noha M Elemam,1,2 Maha Guimei,1,3 Riyad Bendardaf,4 Azzam A Maghazachi1,2 1Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, 27272, United Arabs Emirates; 2Sharjah Institute for Medical Research...
Guardado en:
Autores principales: | Al-ani MR, Raju TK, Hachim MY, Hachim IY, Elemam NM, Guimei M, Bendardaf R, Maghazachi AA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b65f09669a4d44c2b4ee5a84ca4ca498 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Dhaiban S, et al.
Publicado: (2020) -
A Retrospective Analysis of Rituximab Treatment for B Cell Depletion in Different Pediatric Indications
por: Merlin Wennmann, et al.
Publicado: (2021) -
PTI y embarazo: Una experiencia con Rituximab
por: Campoverde V,Priscila, et al.
Publicado: (2017) -
Apoptosis-promoting effect of rituximab-conjugated magnetic nanoprobes on malignant lymphoma cells with CD20 overexpression
por: Song L, et al.
Publicado: (2019) -
Linfoma intravascular, un desafio diagnóstico: Caso clínico
por: Young,Pablo, et al.
Publicado: (2015)